Comparison of the New Fitting Method Cochlear Nucleus Fitting Software (NFS) With the Established Fitting Method Cochlear Nucleus Custom SoundTM Suite (CSS)

NCT ID: NCT02228148

Last Updated: 2018-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2017-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate if the new and simplified fitting method with Cochlear Nucleus Fitting Software (a major component of a suite of tools which form the Clinical Care Innovation) provides Cochlear Implants Recipients with the same hearing outcome as the current and established clinical fitting method with Cochlear Nucleus Custom SoundTM Suite. The Clinical Care Innovation method reduces fitting to simple volume, bass and trebles adjustments, operations which are familiar to anyone who has used an audio player.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NFS

Cochlear Nucleus Fitting Software

Group Type EXPERIMENTAL

NFS

Intervention Type DEVICE

Cochlear Nucleus Fitting Software

CSS

Cochlear Nucleus Custom SoundTM Suite

Group Type ACTIVE_COMPARATOR

CSS

Intervention Type DEVICE

Cochlear Nucleus Custom SoundTM Suite

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NFS

Cochlear Nucleus Fitting Software

Intervention Type DEVICE

CSS

Cochlear Nucleus Custom SoundTM Suite

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newly implanted subjects with available Nucleus Cochlear Implants compatible with CP900 series sound processors (excluding Cochlear Nucleus Hybrid)
* Post linguistically deafened adults (≥ 18 years)
* Unilaterally implanted
* ≤ 15 years of severe to profound deafness prior to implantation
* Subjects who are capable and willing to participate in speech perception tests in local language
* Subjects who are able to provide feedback in form of a written questionnaire (e.g. Speech Spatial Hearing Qualities questionnaire)
* Subjects willing to give their consent to the study

Exclusion Criteria

* Additional handicaps that would prevent participation in evaluations (e.g. visual impairment, blindness)
* Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure/fitting method
* Bilateral implantation
* Hybrid-L (not supported by Nucleus Fitting Software)
* Subjects who already have hearing experience with a Cochlear Implant (e.g. reimplantation, contralateral Cochlear Implant)
* Subjects with single-sided deafness
* Known cochlea malformations
* Subjects who lost their hearing due to meningitis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

numerics data GmbH

UNKNOWN

Sponsor Role collaborator

Cochlear

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bart Volckaerts, PhD

Role: STUDY_DIRECTOR

Cochlear

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Deutsches HörZentrum Hannover der HNO-Klinik der MHH

Hanover, Lower Saxony, Germany

Site Status

Universitätsklinikum Schleswig-Holstein - Campus Kiel, Klinik für Hals, Nasen-, Ohrenheilkunde, Kopf und Halschirurgie

Kiel, Schleswig-Holstein, Germany

Site Status

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital

Zurich, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEL5332

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.